FFilingSight

Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.

Jul 21, 2026 · FilingSight Research

Market Brief — July 21, 2026

Risk-on · Supportive. 28 Buy / 118 Hold / 36 Sell across 182 names. Top conviction: ALL.

MacroDaily BriefRates

Market Brief — July 21, 2026

Auto-generated by FilingSight from live FRED macro data and the latest SEC-derived company reports.

Macro regime

Risk-on · Supportive.

Gauge Status Detail
Growth & Recession Gauge Healthy Healthy.
Inflation Regime Moderating Moderating. Headline CPI +3.5% YoY, core +2.6% YoY; 5Y breakeven 2.28%.
Financial Conditions Neutral Neutral. VIX 18.77, BAA-10Y credit spread 1.59pp.
Policy Stance Near neutral Near neutral. Fed funds 3.63%, real rate 1.06%.

Rates & inflation

Fed funds 3.63%, headline CPI YoY 3.5%, VIX 18.8, yield curve upward-sloping.

Coverage breadth

Across 182 tracked names: 28 bullish, 118 neutral, 36 bearish outlook.

Highest-conviction bullish names:

  • ALL (Allstate Corp.) — Buy, composite score 32, confidence 81%.
  • INTU (Intuit Inc.) — Buy, composite score 32, confidence 83%.
  • CF (CF Industries) — Buy, composite score 32, confidence 82%.
  • META (Meta Platforms Inc.) — Buy, composite score 32, confidence 65%.

Most bearish names:

  • TSLA (Tesla Inc.) — Sell, score -44.
  • ON (ON Semiconductor Corp.) — Sell, score -40.
  • WBD (Warner Bros Discovery) — Sell, score -39.

What to watch

With the Fed holding at 3.63% and CPI sticky at 3.5%, the upward-sloping curve confirms a supportive risk-on regime, though tracked breadth of 28 Buy versus 36 Sell signals amid 118 Holds suggests institutional conviction remains highly selective beneath the benign VIX of 18.8. Focus this week on whether mega-cap earnings durability can extend the momentum seen in META and INTU, while monitoring whether fertilizer demand sustains the cyclical bid in CF and whether ALL can defend its premium pricing trajectory in a softening-rate environment.


FilingSight is informational and educational only, generated from public data. Not investment advice.